Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli - PubMed (original) (raw)
Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli
M Herrero et al. J Gen Microbiol. 1986 Feb.
Abstract
Microcin B17 is a novel peptide antibiotic of low Mr (about 4000) produced by Escherichia coli strains carrying plasmid pMccB17. The action of this microcin in sensitive cells is essentially irreversible, follows single-hit kinetics, and leads to an abrupt arrest of DNA replication and, consequently, to the induction of the SOS response. RecA- and RecBC- strains are hypersensitive to microcin B17. Strains producing a non-cleavable SOS repressor (lexAl mutant) are also more sensitive than wild-type, whereas strains carrying a mutation which causes constitutive expression of the SOS response (spr-55) are less sensitive to microcin. Microcin B17 does not induce the SOS response in cells which do not have an active replication fork. The results suggest that the mode of action of this microcin is different from all other well-characterized microcins and colicins, and from other antibiotics which inhibit DNA replication.
Similar articles
- The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
Collin F, Maxwell A. Collin F, et al. J Mol Biol. 2019 Aug 23;431(18):3400-3426. doi: 10.1016/j.jmb.2019.05.050. Epub 2019 Jun 8. J Mol Biol. 2019. PMID: 31181289 Free PMC article. Review. - Effects of microcin B17 on microcin B17-immune cells.
Herrero M, Kolter R, Moreno F. Herrero M, et al. J Gen Microbiol. 1986 Feb;132(2):403-10. doi: 10.1099/00221287-132-2-403. J Gen Microbiol. 1986. PMID: 3519858 - Evidence that colicin X is microcin B17.
San Millán JL, Kolter R, Moreno F. San Millán JL, et al. J Bacteriol. 1987 Jun;169(6):2899-901. doi: 10.1128/jb.169.6.2899-2901.1987. J Bacteriol. 1987. PMID: 3034869 Free PMC article. - The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine.
Davagnino J, Herrero M, Furlong D, Moreno F, Kolter R. Davagnino J, et al. Proteins. 1986 Nov;1(3):230-8. doi: 10.1002/prot.340010305. Proteins. 1986. PMID: 3329729 - Focus on modified microcins: structural features and mechanisms of action.
Destoumieux-Garzón D, Peduzzi J, Rebuffat S. Destoumieux-Garzón D, et al. Biochimie. 2002 May-Jun;84(5-6):511-9. doi: 10.1016/s0300-9084(02)01411-6. Biochimie. 2002. PMID: 12423795 Review.
Cited by
- Exploring the genetic basis of natural resistance to microcins.
Telhig S, Pham NP, Ben Said L, Rebuffat S, Ouellette M, Zirah S, Fliss I. Telhig S, et al. Microb Genom. 2024 Feb;10(2):001156. doi: 10.1099/mgen.0.001156. Microb Genom. 2024. PMID: 38407259 Free PMC article. - Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides.
Ongpipattanakul C, Desormeaux EK, DiCaprio A, van der Donk WA, Mitchell DA, Nair SK. Ongpipattanakul C, et al. Chem Rev. 2022 Sep 28;122(18):14722-14814. doi: 10.1021/acs.chemrev.2c00210. Epub 2022 Sep 1. Chem Rev. 2022. PMID: 36049139 Free PMC article. Review. - Antimicrobial Peptides: An Update on Classifications and Databases.
Bin Hafeez A, Jiang X, Bergen PJ, Zhu Y. Bin Hafeez A, et al. Int J Mol Sci. 2021 Oct 28;22(21):11691. doi: 10.3390/ijms222111691. Int J Mol Sci. 2021. PMID: 34769122 Free PMC article. Review. - The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
Collin F, Maxwell A. Collin F, et al. J Mol Biol. 2019 Aug 23;431(18):3400-3426. doi: 10.1016/j.jmb.2019.05.050. Epub 2019 Jun 8. J Mol Biol. 2019. PMID: 31181289 Free PMC article. Review. - Non-pathogenic Escherichia coli Enhance Stx2a Production of E. coli O157:H7 Through Both _bamA_-Dependent and Independent Mechanisms.
Xiaoli L, Figler HM, Goswami Banerjee K, Hayes CS, Dudley EG. Xiaoli L, et al. Front Microbiol. 2018 Jun 15;9:1325. doi: 10.3389/fmicb.2018.01325. eCollection 2018. Front Microbiol. 2018. PMID: 29973923 Free PMC article.